Passa al contenuto
Merck

Synthesis of pyrrolo[2,3-d]pyrimidine nucleoside derivatives as potential anti-HCV agents.

Bioorganic chemistry (2006-09-02)
Chamakura V N S Varaprasad, Kanda S Ramasamy, Jean-Luc Girardet, Esmir Gunic, Vicky Lai, Weidong Zhong, Haoyun An, Zhi Hong
ABSTRACT

Several Toyocamycin (4) analogues were examined for their ability to inhibit HCV RNA in a replicon assay. Among the compounds examined 4-methylthio (18) and 5-carboxamide oxime derivatives (23 and 27) of Toyocamycin were found to have good activity and selectivity.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Toyocamycin, ≥98% (HPLC), from Streptomyces rimosus